Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors

Clinical trial NCT00611468 · COMPLETED

Trial details

NCT number: NCT00611468
Sponsor: Accelerated Community Oncology Research Network
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Solid Tumor

Start date: 2006-06-01
Primary completion: 2009-08-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.